Literature DB >> 16302113

Rotavirus serotypes and electropherotypes identified among hospitalised children in São Luís, Maranhão, Brazil.

Cláudia Regina N E da Luz1, Joana D'Arc P Mascarenhas, Yvone B Gabbay, Ana Regina B Motta, Telma Vitorina Ribeiro Lima, Luana da S Soares, Alexandre C Linhares.   

Abstract

During June 1997-June 1999 rotavirus infection was screened in infants aged up to 2 years and hospitalised with acute diarrhoea in São Luís, Northeastern Brazil. Altogether, 128 stool samples were collected from diarrhoeic patients and additional 122 faecal specimens from age and temporal matched inpatients without diarrhoea were obtained; rotavirus positivity rates for these groups were 32.0% (41/128) and 9.8% (12/122), respectively (p < 0.001). Both electropherotyping and serotyping could be performed in 42 (79.2%) of the 53 rotavirus-positive stool samples. Long and short electropherotypes were detected at similar rates--38.1% and 40.5% of specimens, respectively. Overall, a G serotype could be assigned for 35 (83.3%) of specimens, the majority of them (66.7%) bearing G1-serotype specificity. Taking both electropherotypes and serotypes together, G1 rotavirus strains displaying long and short RNA patterns accounted for 30.9% and 19.0% of tested specimens, respectively; all G2 strains had short electropherotype. Rotavirus gastroenteritis was detected year-round and, in 1998, the incidence rates tended to be higher during the second semester than in the first semester: 45.2% and 26.1% (p = 0.13), respectively. Rotavirus infections peaked at the second semester of life with frequencies of 30.1% and 13.5% for diarrhoeic children and controls, respectively. While the six rotavirus strains bearing G2-type specificity were circulating throughout the whole study period, G1 serotypes (n = 27) emerged as from June 1998 onwards, 20 (74.1%) of which clustering in 1998. These data underscore the importance of rotaviruses in the aetiology of severe infantile gastroenteritis in Northeastern Brazil and sustain the concept that a future vaccine should confer protection against more than one serotype.

Entities:  

Mesh:

Year:  2005        PMID: 16302113     DOI: 10.1590/s0036-46652005000500009

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  5 in total

1.  Global seasonality of rotavirus disease.

Authors:  Manish M Patel; Virginia E Pitzer; Wladimir J Alonso; David Vera; Ben Lopman; Jacqueline Tate; Cecile Viboud; Umesh D Parashar
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

2.  Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis.

Authors:  Greice Madeleine Ikeda do Carmo; Catherine Yen; Jennifer Cortes; Alessandra Araújo Siqueira; Wanderson Kleber de Oliveira; Juan José Cortez-Escalante; Ben Lopman; Brendan Flannery; Lucia Helena de Oliveira; Eduardo Hage Carmo; Manish Patel
Journal:  PLoS Med       Date:  2011-04-19       Impact factor: 11.069

3.  Caliciviruses in hospitalized children, São Luís, Maranhão, 1997-1999: detection of norovirus GII.12.

Authors:  Thayara Morais Portal; Jones Anderson Monteiro Siqueira; Larissa Cristina Prado das Neves Costa; Ian Carlos Gomes de Lima; Maria Silvia Sousa de Lucena; Renato da Silva Bandeira; Alexandre da Costa Linhares; Claudia Regina Nunes Eloi da Luz; Yvone Benchimol Gabbay; Hugo Reis Resque
Journal:  Braz J Microbiol       Date:  2016-04-22       Impact factor: 2.476

Review 4.  Human rotavirus in Iran; molecular epidemiology, genetic diversity and recent updates on vaccine advances.

Authors:  Shadi Tavakoli Nick; Seyed Reza Mohebbi; Amir Ghaemi; Seyed Masoud Hosseini
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

5.  Post-vaccine rotavirus genotype distribution in Nairobi County, Kenya.

Authors:  Joshua Ndung'u Gikonyo; Betty Mbatia; Patrick W Okanya; George F O Obiero; Carlene Sang; Duncan Steele; James Nyangao
Journal:  Int J Infect Dis       Date:  2020-09-06       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.